Certified by Founder Lodge
Action Potential Venture Capital

INVESTOR
1 Disclosed Funding Rounds $150,000,000
4 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Action Potential Venture Capital (APVC) is GSK's bioelectronic medicines venture fund. APVC is focused on the next generation of peripheral neuromodulation medical devices, and invests in co
Company | Date | Round | Raised |
---|---|---|---|
![]() |
April, 17 ,2023 | Unknown | $150,000,000 |
![]() |
June, 27 ,2023 | Series C | $72,000,000 |
![]() |
July, 16 ,2024 | Series D | $23,000,000 |
![]() |
March, 18 ,2025 | Series F | $65,000,000 |